Sitemap

• Medical Database
• News
• Images
• Ask the experts
• Studies
• Products
  • Symbicort
    • Asthma - Who will benefit from Symbicort?
    • Asthma - Adjustable maintenance dosing
    • Asthma - Onset of action
    • Asthma - Efficacy
    • Asthma - Symbicort compared with Seretide
    • Asthma - Safety
    • Asthma - Cost-effectiveness
    • Asthma - References
    • COPD - Who will benefit from Symbicort?
    • COPD - Clinical studies
    • COPD - Exacerbations
    • COPD - Quality of life
    • COPD - Lung function
    • COPD - Symptom relief
    • COPD - Safety
    • COPD - Cost effective
    • COPD - References
    • Device benefits
    • Different formulations of Symbicort
    • Prescribing information
  • Oxis
    • Fast onset of action
    • Long duration of action
    • Effective as needed therapy
    • Effective maintenance therapy
    • Unique pharmacological characteristics
    • Favourable safety profile
    • References
    • Different formulations of Oxis
    • Alternative names for Oxis
    • Prescribing information
  • Pulmicort
    • Pulmicort - place in therapy
    • Pulmicort and asthma of different degrees of severity
    • Treatment with Pulmicort - general aspects
    • Pulmicort in mild asthma
    • Early intervention with Pulmicort
    • Once daily Pulmicort
    • Paediatric asthma
    • Safety of Pulmicort Turbuhaler
    • Airway selectivity and therapeutic ratio
    • Pulmicort in relation to other inhaled corticosteroids
    • Treatment with Pulmicort vs. treatment with other anti-asthma drugs
    • Pulmicort as part of Symbicort®
    • Pulmicort versatile dosing
    • Pulmicort Respules®
    • Pulmicort in COPD
    • Pulmicort and other pulmonary disease
    • Different formulations of Pulmicort
    • Alternative names for Pulmicort
    • Prescribing information
  • Accolate
    • Highly potent and selective cysteinyl leukotriene receptor antagonist
    • Blocks the effects of leukotriene-related inflammatory response in airways
    • Effective control of asthma, either in combination with other controller therapies or as an alternative to first-line use of low-dose inhaled glucocorticosteroids
    • Complementary mechanism of action to inhaled corticosteroids
    • Provides the confidence of day and night control of asthma
    • Unsurpassed compliance from twice-daily tablet therapy
    • Well tolerated in long-term treatment
    • Different formulations of Accolate
    • Alternative names for Accolate
    • Bibliography
    • Prescribing information
  • Rhinocort
    • Pharmacology
    • Place in therapy
    • Effective, once-daily relief of allergic rhinitis
    • Benefits to patients
    • Effective once-daily relief of nasal polyposis
    • Effective in the treatment of stable, adult, chronic rhinosinusitis
    • Well tolerated
    • Cost-effective
    • Different formulations of Rhinocort
    • Alternative names for Rhinocort
    • Prescribing information
  • Bricanyl
    • Immediate bronchodilation in children and adults
    • Effective in acute asthma
    • Effective in exercise-induced asthma
    • Well tolerated
    • Easy to use and patient preference
    • Therapeutic effectiveness even at high temperatures and high humidity
    • Different formulations of Bricanyl
    • Alternative names for Bricanyl
    • Bibliography
    • Prescribing information
  • Bambec
    • Effective bronchodilation over the full 24-hour period
    • Reduces diurnal variation in lung function
    • Especially effective in patients with nocturnal asthma
    • Effective and well tolerated in long-term treatment
    • Especially suitable for children
    • Suitable for the elderly
    • At least as effective as oral terbutaline (t.i.d.), CR salbutamol (b.i.d.), and CR theophylline (b.i.d.)
    • At least as effective and well-tolerated as inhaled salmeterol
    • A prodrug of the beta2-adrenergic agonist terbutaline
    • Different formulations of Bambec
    • Alternative names for Bambec
    • Bibliography
    • Prescribing information
  • Turbuhaler
    • Enhanced pulmonary deposition translates into greater clinical efficacy
    • Easy to use
    • Applicable to almost all patients
    • The patient’s choice
    • Environmentally friendly – CFC free
    • Accurate dosing
    • Enhanced pulmonary deposition
    • Fewer local side effects than with pMDIs
    • Alternative names for Turbuhaler
    • Bibliography
  • Pulmicort Respules
    • Pulmicort Respules®
  • pMDIs
    • How to use a pMDI correctly
    • Lung deposition of AstraZeneca’s pMDIs with and without a spacer
    • Bibliography
  • NebuChamber
    • A metal spacer entirely free of electrostatic charges
    • NebuChamber delivers: Consistent and reliable doses
    • A high proportion of drug as fine droplets
    • Cost-effective treatment
    • Consistent doses regardless of washing or drying procedures
    • Treatment suitable for children
    • Alternative names for NebuChamber
    • Bibliography
  • Nebuhaler
    • Assists in the effective use of AstraZeneca’s pMDIs by patients who have problems co-ordinating actuation of the inhaler with inhalation
    • Suitable for adults and children
    • Provides greater lung deposition of drug than pMDI alone
    • Reduces oropharyngeal drug deposition
    • Effective delivery of inhaled budesonide to pre-school children with asthma
    • Effective delivery of inhaled terbutaline to pre-school and school-aged children
    • Alternative names for Nebuhaler
    • Bibliography
• Cases
• Links